Brazil
FUTR BIO is a pioneering biotechnology startup headquartered in Brazil, established in 2022. The company is devoted to innovating the field of mRNA vaccines with an aim to prevent and cure diseases, specifically focusing on infections and cancer. With the rallying cry of "We develop next generation mRNA vaccines to prevent and cure diseases such as infections and cancer," they are making strides in healthcare solutions.
The hallmark of FUTR BIO's innovation lies in its proprietary mRNA vaccine technology, which integrates natural UTRs and molecular boosters. This advanced technology aims to elicit superior immune responses, setting new benchmarks in the fight against infectious diseases and cancer, and placing them at the forefront of modern biotechnology advancements.
As of February 12, 2022, FUTR BIO secured a Pre Seed Round investment, showcasing investor confidence and potential for robust growth. The investment was led by Vesper Ventures SA, a key player backing visionary biotechnological initiatives.
-logo.jpg "Access to Advanced Health Institute (AAHI)"){kind=logo}